Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for Chronic Lymphocytic Leukemia

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified August 2004 by Corixa Corporation.
Recruitment status was:  Active, not recruiting
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by:
Corixa Corporation
ClinicalTrials.gov Identifier:
NCT00022880
First received: August 15, 2001
Last updated: June 23, 2005
Last verified: August 2004
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given